PRIVATE FUNDS
208 Form D Notices Indexed September 28, 2026, Including Filings From Pfaradigm Health and Vertical Longevity Pharmaceuticals
Regulatory filings indexed on September 28, 2026, include 135 new notices and 73 amendments. The registry captures cumulative offering totals reported by issuers across diverse industry groups, including health care and biotechnology.
By Daniel Mercer·Edition ·2 min read
The daily index of Form D notices for September 28, 2026, reflects a total of 208 filings. This figure includes 135 new notices and 73 amendments indexed during the day. The index captures a variety of issuer types and industries, with notices filed as observations of activity rather than as a single sector or offering trend.
Reported offering amounts represent the cumulative total as stated in each individual filing, rather than the amount of capital raised on the index date itself. Individual notices may contain earlier filing dates, and issuer identity as well as signatory roles are presented as filed by the entities.
[PFARADIGM Health, Inc.](#issuer:2156162), a corporation incorporated in Delaware, filed a notice indexed on September 28, 2026. The filing categorizes the issuer under the Other Health Care industry group. The document lists Allan Zingeler as the chief executive officer and director who signed the notice on September 25, 2026.
The PFARADIGM Health, Inc. filing reports a total offering amount of $56.1M. The document indicates that $31.1M has been sold, with $25.0M remaining. These figures reflect the cumulative totals as reported in the current filing, not money raised during the reporting day.
[Vertical Longevity Pharmaceuticals, Inc.](#issuer:2087846), another Delaware-incorporated corporation, submitted a notice indexed on September 28, 2026. This issuer is classified under the Biotechnology industry. The filing names David P. Scieszka, whose title is reported in the filing as CEO, as the signatory. He signed the document on September 25, 2026.
Vertical Longevity Pharmaceuticals, Inc. reports a cumulative total offering amount of $0.1M in its latest filing. The notice indicates the total amount sold is $0.1M, with $0 remaining to be sold. As with all index entries, these amounts are cumulative as reported in this filing.
| Category | Count |
|---|---|
| New notices | 135 |
| Amendments | 73 |
Complete filing list
All 208 Form D notices in the covered daily index, listed alphabetically by issuer. The filing date is preserved as reported; a daily index can include a notice with an earlier filing date. Each row links to its SEC filing.
Showing rows 76–100 of 208. The CSV contains the complete table.
| Issuer | Filing date | Daily index date | Form | Accession | SEC filing |
|---|---|---|---|---|---|
| Eca Boulware LLC | 09/28/2026 | 09/28/2026 | D | 0002150562-26-000001 | View filing |
| Eca Chateau LLC | 09/28/2026 | 09/28/2026 | D | 0002150573-26-000001 | View filing |
| Eca Longview TX LLC | 09/28/2026 | 09/28/2026 | D | 0002150538-26-000001 | View filing |
| Ecp O13, LLC | 09/28/2026 | 09/28/2026 | D | 0002074922-26-000001 | View filing |
| Emmi Health, Inc | 09/28/2026 | 09/28/2026 | D | 0002156262-26-000001 | View filing |
| EquityZen Growth Technology Fund LLC - Series 2375 | 09/28/2026 | 09/28/2026 | D | 0002139212-26-000001 | View filing |
| Escalate Capital V, LP | 09/28/2026 | 09/28/2026 | D | 0002093839-26-000003 | View filing |
| Evia Bio, Inc. | 09/28/2026 | 09/28/2026 | D | 0001954759-26-000004 | View filing |
| Evoke Innovation Fund II, LP | 09/28/2026 | 09/28/2026 | D/A | 0002092610-26-000003 | View filing |
| Evoke Royalty Solutions Fund II (Oberland), LP | 09/28/2026 | 09/28/2026 | D/A | 0002092617-26-000002 | View filing |
| Evoke Secondaries Fund VI (BR VI), LP | 09/28/2026 | 09/28/2026 | D/A | 0002072410-26-000002 | View filing |
| Exa Labs Inc. | 09/28/2026 | 09/28/2026 | D | 0002024864-26-000003 | View filing |
| Expedition Function Co-Invest LP | 09/28/2026 | 09/28/2026 | D | 0001315863-26-000693 | View filing |
| Ffe SPV I LLC | 09/28/2026 | 09/28/2026 | D | 0002153805-26-000001 | View filing |
| Fieldpoint Private Holdings, Inc. | 09/28/2026 | 09/28/2026 | D | 0001870391-26-000002 | View filing |
| Foundational Fund, LP | 09/28/2026 | 09/28/2026 | D/A | 0001996520-26-000001 | View filing |
| Frequency Exchange Corp. | 09/28/2026 | 09/28/2026 | D | 0001816133-26-000001 | View filing |
| Full Stop Holdings LLC | 09/28/2026 | 09/28/2026 | D | 0002157033-26-000001 | View filing |
| Gaingels AllJoined LLC | 09/28/2026 | 09/28/2026 | D | 0002147616-26-000001 | View filing |
| Gaingels Firehawk August 2026 LLC | 09/28/2026 | 09/28/2026 | D | 0002151565-26-000001 | View filing |
| Gaingels Palabra AI LLC | 09/28/2026 | 09/28/2026 | D | 0002154903-26-000001 | View filing |
| Gemspring Growth Solutions Executive II, LP | 09/28/2026 | 09/28/2026 | D/A | 0000905148-26-004274 | View filing |
| Gen AI Fund H a Series of Fog Ventures Fund III LLC | 09/28/2026 | 09/28/2026 | D | 0002156927-26-000001 | View filing |
| GID Commercial Real Estate Credit Fund LP | 09/28/2026 | 09/28/2026 | D/A | 0002088816-26-000001 | View filing |
| Glean IP Holdings Inc. | 09/28/2026 | 09/28/2026 | D/A | 0002088694-26-000001 | View filing |